Pound Sterling (Change)

£ GBP store

My Cart (0)

anti-Phospholamban A1 Antibody (A010-14)

SKU# A010-14

Be the first to review this product

Availability: In stock

£193.59
anti-Phospholamban A1 Antibody (A010-14) is available for purchase in increments of 1

Quick Overview

Description: Mouse monoclonal antibody to phospholamban.


Unit Volume: 20 μg


Tested Applications: Western blot (1:5000 dilution), IHC Microscopy (1:200 dilution), Ca2+ pump assay (1:500 dilution)


Antibody form: Lyophilised Affinity Purified IgG. 


Species recognition: All mammalian species



Click on image to zoom

More Views

Summary

Description: A fully validated, highly specific, affinity purified mouse monoclonal antibody to phospholamban (anti-PLB | anti-PLN)

Background: The majority of calcium required for muscle contraction is mobilised from the Sarcoplasmic Reticulum (SR), to which it has to return to in order to facilitate relaxation. The (Ca2+- Mg2+) ATPase enzyme is responsible for the sequestration of calcium after its release from the SR, and is controlled by another sarcoplasmic reticulum protein called Phospholamban (PLB) in cardiac, smooth and slow-twitch skeletal muscle. The monoclonal antibody (A1) was raised against bovine cardiac PLB  and recognises an epitope comprising of residues 7LTRSAIRRAS16. The antibody reacts with all forms of phospholamban PLB: monomer, oligomers, phosphorylated and non-phosphorylated. The antibody stimulates Ca2+ pump activity upon binding to PLB, to an extent equivalent to stoichiometric phosphorylation of PLB Manipulation of SERCA2:PLB ratios is a therapeutic strategy for heart failure. Elimination of PLB boosts SR Ca2+-load which can exacerbate pathological outcomes (apoptosis, arrhythmias) when combined with other alterations in SR function.

Unit Volume: 20 μg

Tested Applications: Western blot (1:5000 dilution), IHC Microscopy (1:200 dilution), Ca2+ pump assays (1:500 dilution)

Antibody form: Lyophilised Affinity Purified IgG. 

Species recognition: All mammalian species

Full Publication list: 45 papers

 

Selected Publications:

SUMO1-dependent modulation of SERCA2a in heart failure.

W.J., and Hajjar, R.J. (2011). . Nature 477, 601-605.

Carbon monoxide exposure enhances arrhythmia after cardiac stress: involvement of oxidative stress. 

André, L., Gouzi, F., Thireau, J., Meyer, G., Boissiere, J., Delage, M., Abdellaoui, A., Feillet-Coudray, C., Fouret, G., Cristol, J.P., et al. (2011). Basic Res Cardiol 106, 1235-1246.

 




Details
GPB £193.59
Storage Lyophilised: 4 °C Reconstituted:-80 °C
Epitope/Isoform Alignment N/A
Epitope/Species Alignment

Ep/Sp Alignment

Data Sheet

A010-14

(PDF 231 kB)

MSDS

A010-14

Product Tags

Use spaces to separate tags. Use single quotes (') for phrases.